Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2010-10-13 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings
2010-10-13 Danish
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a formal announcement titled 'Company release No 21/2010' issued to 'NASDAQ OMX Copenhagen A/S' on October 13, 2010. The content details the approval of a new product (JEXT®) in Europe and discusses future launch plans, expected improvements to gross margin and earnings. This structure—a brief, time-sensitive announcement of a significant business event (product approval/launch) directed to a stock exchange—is characteristic of a general regulatory filing or news release that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a formal announcement to the exchange regarding a business development, and it is not a specific report like an Earnings Release (ER) or Interim Report (IR), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements.
2010-10-13 English
Regulatory Filings 2010
Regulatory Filings
2010-10-07 Danish
Regulatory Filings 2010
Regulatory Filings
2010-10-07 English
Director's Dealing 2010
Director's Dealing Classification · 99% confidence The document explicitly reports on 'transactions with ALK-Abelló A/S B-shares by managerial staff and their related parties' pursuant to securities trading regulations. It details a 'Purchase' transaction by an executive (CFO). This directly matches the definition for Director's Dealing (insider trades by executives/directors).
2010-09-03 English
Regulatory Filings 2010
Regulatory Filings
2010-09-03 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.